Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

A Safety and Immunogenicity Phase IB Study of CryJ2-DNA-Lysosomal Associated Membrane Protein (CryJ2 -DNA-LAMP) Plasmid Assessing the Long Term Safety of Previously Treated Subjects

Immunomic Therapeutics, Inc. · 2013
ClinicalTrials.gov · Datasets · License: Public Domain · 2013
Open Source ↗
allergic rhinoconjunctivitis, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 814042
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.